샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941428

메조테라피 제품 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 폼팩터별, 적응증별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2034년)

Mesotherapy Products Market Size, Share & Trends Analysis Report By Product, By Form Factors, By Indication, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2034
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

메조테라피 제품 시장 요약

세계의 메조테라피 제품 시장 규모는 2024년에 7,740만 달러로 평가되었고, 2034년까지 1억 6,670만 달러에 이를 것으로 예측됩니다.

2025년부터 2034년까지 연평균 복합 성장률(CAGR) 8.2%를 나타낼 것으로 예측됩니다. 이러한 성장은 저침습적 미용 치료에 대한 수요 증가, 피부 품질 개선에 대한 관심 증가, 예방적 안티에이징 솔루션에 대한 소비자 관심 확대에 힘입어 성장세를 보이고 있습니다.

탈수, 잔주름, 색소침착, 탈모 등의 고민이 증가함에 따라, 다운타임을 최소화하고 자연스러운 개선 효과를 제공하는 주사제의 채택이 강화되고 있습니다. 히알루론산 리바이탈라이저, 폴리뉴클레오티드 주사제, 맞춤형 메소칵테일의 발전으로 치료의 안전성과 유효성이 더욱 향상되어 임상에서 폭넓게 사용되고 있습니다.

기존 수술에 따른 위험과 회복 기간 없이 눈에 보이는 효과를 얻을 수 있는 비수술적 미용 시술을 선택하는 사람들이 늘고 있습니다. 2023년에는 전 세계적으로 최소침습 시술에 대한 수요가 급증할 것으로 예상되며, 미국성형외과학회(ASPS)에 따르면 같은 해 최소침습 시술은 약 7% 증가해 외과적 시술을 능가하는 성장세를 보일 것으로 전망됐습니다. 이러한 변화는 위험성이 적고, 회복 기간이 짧으며, 총비용이 낮으면서도 효과적인 미용 결과를 제공하는 치료법에 대한 소비자의 선호도 변화를 반영하고 있습니다. 환자들은 대부분 외래 환경에서 신속하게 시행할 수 있고, 일상 생활로의 복귀를 최소화할 수 있는 시술을 점점 더 많이 원하고 있습니다. 이러한 장점에 대한 인식 증가와 치료 결과를 개선하는 기술 및 제품의 발전과 함께, 기존의 수술적 대안보다 최소침습적 옵션을 선택하는 사람들이 증가하고 있습니다.

젊은 층의 탈모증과 피부질환 증가는 메조테라피 제품 시장의 성장을 견인하는 요인으로 작용하고 있습니다. 젊은 성인층에서는 탈모가 일찍 진행되어 남성의 약 25%가 30세 이전에 탈모가 시작되며, 탈모증은 여성의 상당수에게도 영향을 미치고 있습니다. 이러한 조기 발병으로 인해 빠른 효과와 최소의 다운타임으로 미용 및 회복 치료에 대한 수요가 증가하고 있습니다. 동시에, 일반적인 피부 트러블도 젊은 층에서 높은 유병률을 유지하고 있습니다. 여드름은 12-25세의 약 85%에게 영향을 미치며, 전 세계적으로 가장 흔한 피부 트러블 중 하나입니다. 여드름이 지속되거나 흉터를 동반한 여드름은 젊은 환자들에게 외용제를 넘어 의료기관에서 치료를 받도록 유도하는 경우가 많으며, 이러한 증상은 눈에 보이는 효과를 약속하는 클리닉 기반 주사 요법이나 저침습적 솔루션에 대한 소비자의 욕구를 높이고 있습니다.

미용 클리닉의 급속한 확대와 의료 관광 증가 추세는 메조테라피 제품에 대한 수요 증가의 주요 원동력이 되고 있습니다. 최근 인도 등에서는 레이저와 에너지를 이용한 피부 재생부터 주사제, 메조테라피에 이르기까지 미용-미용 치료를 제공하는 전문 클리닉이 크게 증가하고 있습니다. 의료관광은 이러한 추세를 더욱 가속화시키고 있습니다. 해외에서 온 환자들은 유럽과 미국에 비해 훨씬 저렴한 비용으로 양질의 치료를 받기 위해 인도 등의 국가를 찾는 경우가 증가하고 있습니다. 예를 들어, 인도의 한 대형 미용 클리닉 체인은 최근 환자의 15% 이상이 해외에서 온 환자라고 보고하여, 세계 수요가 클리닉의 사업 규모에 큰 기여를 하고 있는 현실을 보여주고 있습니다.

자주 묻는 질문

  • 메조테라피 제품 시장 규모는 어떻게 예측되나요?
  • 메조테라피 제품 시장의 성장 요인은 무엇인가요?
  • 젊은 층에서 메조테라피 제품 수요가 증가하는 이유는 무엇인가요?
  • 미용 클리닉의 확대가 메조테라피 제품 시장에 미치는 영향은 무엇인가요?
  • 2023년 최소침습 시술의 수요는 어떻게 변할 것으로 예상되나요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 메조테라피 제품 시장 변수, 동향, 범위

제4장 메조테라피 제품 시장 : 제품별 추정 및 동향 분석

제5장 메조테라피 제품 시장 : 폼팩터별 추정 및 동향 분석

제6장 메조테라피 제품 시장 : 적응증별 추정 및 동향 분석

제7장 메조테라피 제품 시장 : 용도별 추정 및 동향 분석

제8장 메조테라피 제품 시장 : 최종 용도별 추정 및 동향 분석

제9장 메조테라피 제품 시장 : 지역별 추정 및 동향 분석

제10장 경쟁 구도

LSH

Mesotherapy Products Market Summary

The global mesotherapy products market size was valued at USD 77.4 million in 2024 and is projected to reach USD 166.7 million by 2034, growing at a CAGR of 8.2% from 2025 to 2034. This growth is driven by the rising demand for minimally invasive aesthetic treatments, increasing focus on skin quality enhancement, and expanding consumer interest in preventive anti-aging solutions.

The growing prevalence of concerns such as dehydration, fine lines, pigmentation, and hair thinning has strengthened the adoption of injectable formulations that offer natural-looking improvements with minimal downtime. Advancements in hyaluronic acid revitalizers, polynucleotide injectables, and customized meso-cocktails have further improved treatment safety and efficacy, supporting wider clinical use.

People are increasingly opting for non-surgical cosmetic enhancements that provide visible results without the risks and recovery time associated with traditional surgery. The global demand for minimally invasive procedures surged in 2023; according to the American Society of Plastic Surgeons (ASPS), minimally invasive procedures grew by about 7% that year, outpacing surgical procedures. This shift reflects changing consumer preferences toward treatments that provide effective cosmetic results with fewer risks, shorter recovery periods, and lower overall costs. Patients are increasingly seeking procedures that can be performed quickly, often in outpatient settings, allowing them to return to their daily routines with minimal interruption. Growing awareness of these benefits, combined with advancements in technologies and products that enhance treatment outcomes, is encouraging more people to choose minimally invasive options over traditional surgical alternatives.

Rising hair loss and skin disorders among younger people are becoming clear drivers for growth in the mesotherapy products market. Young adults are experiencing hair thinning at an earlier age: approximately 25% of men begin losing hair by age 30, and hair-loss conditions also affect a substantial share of women. This early onset increases demand for cosmetic and restorative treatments that work quickly and with minimal downtime. At the same time, common skin problems remain highly prevalent in younger age groups. Acne affects roughly 85% of people aged 12-25 and continues to be one of the top skin complaints worldwide; persistent or scarring acne often pushes younger patients toward in-clinic treatments beyond topical drugs. These conditions heighten consumer willingness to try clinic-based, injectable, and minimally invasive solutions that promise visible results.

The rapid expansion of aesthetic clinics and the rising trend of medical tourism are becoming key drivers of the growing demand for mesotherapy products. In recent years, countries such as India have seen a significant increase in specialized clinics offering cosmetic and aesthetic treatments, ranging from laser and energy-based skin rejuvenation to injectables and mesotherapy. Medical tourism amplifies this trend further. Patients from abroad are increasingly traveling to countries like India, drawn by high quality treatments at costs often substantially lower than in Western nations. For example, a major aesthetic clinic chain in India recently reported that over 15% of its patients come from overseas, illustrating how global demand contributes significantly to the clinic's business volume.

Global Mesotherapy Products Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. Forthis study, Grand View Research has segmented the global mesotherapy products market report based on product, form factor, indication, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2034)
  • Hyaluronic Acid (non-crosslinked) Revitalizers
  • Polynucleotides (PN) / PDRN Injectables
  • Vitamin, Amino Acid & Peptide Cocktails
  • Antioxidants & Whitening Complexes
  • Minerals, Trace elements, Coenzymes
  • Others
  • Form Factors Outlook (Revenue, USD Million, 2021 - 2034)
  • Vials
  • Ampoules
  • Prefilled Syringes (PFS)
  • Indication Outlook (Revenue, USD Million, 2021 - 2034)
  • Aging/Revitalization (hydration, texture, glow, fine lines)
  • Firming/Tightening (skin laxity, sagging, body firming)
  • Brightening/Anti-dark spots (pigmentation, photodamage)
  • Anti-cellulite/Lipolytic
  • Hair/Scalp revitalization (density, quality, hair loss support)
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2034)
  • Face
    • Full Face (General Revitalization)
    • Periorbital Area
    • Perioral/Lip Zone
    • Cheeks/Mid-face
    • Forehead/Upper face
  • Body
  • Hair/Scalp
  • End Use Outlook (Revenue, USD Million, 2021 - 2034)
  • Hospitals & Clinics
  • Dermatology Clinics
  • Aesthetic Clinics/MedSpas
    • Chain-based MedSpas
    • Standalone MedSpas
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2034)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Portugal
    • Romania
    • Bulgaria
    • Czech Republic
    • Denmark
    • Sweden
    • Norway
    • Russia
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Peru
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Iran

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Form Factor
    • 1.2.3. Indication
    • 1.2.4. Application
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in the Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in Middle East and Africa
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Form Factor outlook
    • 2.2.3. Indication outlook
    • 2.2.4. Application outlook
    • 2.2.5. End Use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Mesotherapy Products Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Mesotherapy Products Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Mesotherapy Products Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Mesotherapy Products Market: Product Movement Analysis
  • 4.3. Mesotherapy Products Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
  • 4.5. Hyaluronic Acid (non-crosslinked) Revitalizers
    • 4.5.1. Hyaluronic Acid (non-crosslinked) Revitalizers Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 4.6. Polynucleotides (PN) / PDRN Injectables
    • 4.6.1. Polynucleotides (PN) / PDRN Injectables Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 4.7. Vitamin, Amino Acid & Peptide Cocktails
    • 4.7.1. Vitamin, Amino Acid & Peptide Cocktails Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 4.8. Antioxidants & Whitening Complexes
    • 4.8.1. Antioxidants & Whitening Complexes Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 4.9. Minerals, Trace elements, Coenzymes
    • 4.9.1. Minerals, Trace elements, Coenzymes Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 5. Mesotherapy Products Market: Form Factor Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Mesotherapy Products Market: Form Factor Movement Analysis
  • 5.3. Mesotherapy Products Market by Form Factor Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
  • 5.5. Vials
    • 5.5.1. Vials Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 5.6. Ampoules
    • 5.6.1. Ampoules Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 5.7. Prefilled Syringes (PFS)
    • 5.7.1. Prefilled Syringes (PFS) Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 6. Mesotherapy Products Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Mesotherapy Products Market: Indication Movement Analysis
  • 6.3. Mesotherapy Products Market by Indication Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
  • 6.5. Aging / Revitalization (hydration, texture, glow, fine lines)
    • 6.5.1. Aging / Revitalization (hydration, texture, glow, fine lines) Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 6.6. Firming / Tightening (skin laxity, sagging, body firming)
    • 6.6.1. Firming / Tightening (skin laxity, sagging, body firming) Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 6.7. Brightening / Anti-dark spots (pigmentation, photodamage)
    • 6.7.1. Brightening / Anti-dark spots (pigmentation, photodamage) Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 6.8. Anti-cellulite / Lipolytic
    • 6.8.1. Anti-cellulite / Lipolytic Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 6.9. Hair / Scalp revitalization (density, quality, hair loss support)
    • 6.9.1. Hair / Scalp revitalization (density, quality, hair loss support) Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 7. Mesotherapy Products Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Mesotherapy Products Market: Application Movement Analysis
  • 7.3. Mesotherapy Products Market by Application Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034, for the following
  • 7.5. Face
    • 7.5.1. Face Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 7.5.2. Full Face (General Revitalization)
      • 7.5.2.1. Full Face Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 7.5.3. Periorbital Area
      • 7.5.3.1. Periorbital Area Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 7.5.4. Perioral / Lip Zone
      • 7.5.4.1. Perioral / Lip Zone Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 7.5.5. Cheeks/Mid-face
      • 7.5.5.1. Cheeks/Mid-face Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 7.5.6. Forehead/ Upper face
      • 7.5.6.1. Forehead/Upper face Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 7.6. Body
    • 7.6.1. Body Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 7.7. Hair/Scalp
    • 7.7.1. Hair/Scalp Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 8. Mesotherapy Products Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Mesotherapy Products Market: End Use Movement Analysis
  • 8.3. Mesotherapy Products Market by End Use Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034, for the following
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 8.6. Dermatology Clinics
    • 8.6.1. Dermatology Clinics Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 8.7. Aesthetic Clinics/MedSpas
    • 8.7.1. Aesthetic Clinics/MedSpas Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 8.7.2. Chain-based MedSpas
      • 8.7.2.1. Clinic-based MedSpas Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 8.7.3. Standalone MedSpas
      • 8.7.3.1. Standalone MedSpas Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 8.8. Others
    • 8.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 9. Mesotherapy Products Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Regional Mesotherapy Products Market Movement Analysis
  • 9.3. Mesotherapy Products Market: Regional Estimates & Trend Analysis by Product & End Use
  • 9.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
  • 9.5. North America
    • 9.5.1. North America Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.2. U.S.
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Reimbursement Scenario
      • 9.5.2.5. U.S. Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.3. Canada
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Reimbursement Scenario
      • 9.5.3.5. Canada Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.4. Europe
    • 9.5.5. Europe Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.6. UK
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Reimbursement Scenario
      • 9.5.6.5. UK Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.7. Germany
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Reimbursement Scenario
      • 9.5.7.5. Germany Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.8. France
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Competitive Scenario
      • 9.5.8.3. Regulatory Framework
      • 9.5.8.4. Reimbursement Scenario
      • 9.5.8.5. France Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.9. Italy
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Competitive Scenario
      • 9.5.9.3. Regulatory Framework
      • 9.5.9.4. Reimbursement Scenario
      • 9.5.9.5. Italy Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.10. Spain
      • 9.5.10.1. Key Country Dynamics
      • 9.5.10.2. Competitive Scenario
      • 9.5.10.3. Regulatory Framework
      • 9.5.10.4. Reimbursement Scenario
      • 9.5.10.5. Spain Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.11. Denmark
      • 9.5.11.1. Key Country Dynamics
      • 9.5.11.2. Competitive Scenario
      • 9.5.11.3. Regulatory Framework
      • 9.5.11.4. Reimbursement Scenario
      • 9.5.11.5. Denmark Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.12. Sweden
      • 9.5.12.1. Key Country Dynamics
      • 9.5.12.2. Competitive Scenario
      • 9.5.12.3. Regulatory Framework
      • 9.5.12.4. Reimbursement Scenario
      • 9.5.12.5. Sweden Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.13. Norway
      • 9.5.13.1. Key Country Dynamics
      • 9.5.13.2. Competitive Scenario
      • 9.5.13.3. Regulatory Framework
      • 9.5.13.4. Reimbursement Scenario
      • 9.5.13.5. Norway Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.14. Russia
      • 9.5.14.1. Key Country Dynamics
      • 9.5.14.2. Competitive Scenario
      • 9.5.14.3. Regulatory Framework
      • 9.5.14.4. Reimbursement Scenario
      • 9.5.14.5. Russia Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.15. Portugal
      • 9.5.15.1. Key Country Dynamics
      • 9.5.15.2. Competitive Scenario
      • 9.5.15.3. Regulatory Framework
      • 9.5.15.4. Reimbursement Scenario
      • 9.5.15.5. Portugal Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.16. Romania
      • 9.5.16.1. Key Country Dynamics
      • 9.5.16.2. Competitive Scenario
      • 9.5.16.3. Regulatory Framework
      • 9.5.16.4. Reimbursement Scenario
      • 9.5.16.5. Romania Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.17. Bulgaria
      • 9.5.17.1. Key Country Dynamics
      • 9.5.17.2. Competitive Scenario
      • 9.5.17.3. Regulatory Framework
      • 9.5.17.4. Reimbursement Scenario
      • 9.5.17.5. Bulgaria Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.5.18. Czech Republic
      • 9.5.18.1. Key Country Dynamics
      • 9.5.18.2. Competitive Scenario
      • 9.5.18.3. Regulatory Framework
      • 9.5.18.4. Reimbursement Scenario
      • 9.5.18.5. Czech Republic Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Reimbursement Scenario
      • 9.6.2.5. Japan Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Reimbursement Scenario
      • 9.6.3.5. China Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.6.4. South Korea
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Reimbursement Scenario
      • 9.6.4.5. South Korea Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.6.5. Thailand
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Reimbursement Scenario
      • 9.6.5.5. Thailand Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. Reimbursement Scenario
      • 9.7.2.5. Brazil Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Reimbursement Scenario
      • 9.7.3.5. Argentina Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.7.4. Mexico
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. Reimbursement Scenario
      • 9.7.4.5. Mexico Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.7.5. Peru
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Reimbursement Scenario
      • 9.7.5.5. Peru Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.7.6. Colombia
      • 9.7.6.1. Key Country Dynamics
      • 9.7.6.2. Competitive Scenario
      • 9.7.6.3. Regulatory Framework
      • 9.7.6.4. Reimbursement Scenario
      • 9.7.6.5. Colombia Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
  • 9.8. Middle East & Africa
    • 9.8.1. Middle East & Africa Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Competitive Scenario
      • 9.8.2.3. Regulatory Framework
      • 9.8.2.4. Reimbursement Scenario
      • 9.8.2.5. South Africa Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Competitive Scenario
      • 9.8.3.3. Regulatory Framework
      • 9.8.3.4. Reimbursement Scenario
      • 9.8.3.5. Saudi Arabia Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Competitive Scenario
      • 9.8.4.3. Regulatory Framework
      • 9.8.4.4. Reimbursement Scenario
      • 9.8.4.5. UAE Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Competitive Scenario
      • 9.8.5.3. Regulatory Framework
      • 9.8.5.4. Reimbursement Scenario
      • 9.8.5.5. Kuwait Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)
    • 9.8.6. Iran
      • 9.8.6.1. Key Country Dynamics
      • 9.8.6.2. Competitive Scenario
      • 9.8.6.3. Regulatory Framework
      • 9.8.6.4. Reimbursement Scenario
      • 9.8.6.5. Iran Mesotherapy Products Market Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Key Company Profiles
    • 10.2.1. Laboratoires FILLMED
      • 10.2.1.1. Company Overview
      • 10.2.1.2. Financial Performance
      • 10.2.1.3. Product Benchmarking
      • 10.2.1.4. Strategic Initiatives
    • 10.2.2. Revitacare
      • 10.2.2.1. Company Overview
      • 10.2.2.2. Financial Performance
      • 10.2.2.3. Product Benchmarking
      • 10.2.2.4. Strategic Initiatives
    • 10.2.3. Mesoestetic
      • 10.2.3.1. Company Overview
      • 10.2.3.2. Financial Performance
      • 10.2.3.3. Product Benchmarking
      • 10.2.3.4. Strategic Initiatives
    • 10.2.4. Mastelli s.r.l.
      • 10.2.4.1. Company Overview
      • 10.2.4.2. Financial Performance
      • 10.2.4.3. Product Benchmarking
      • 10.2.4.4. Strategic Initiatives
    • 10.2.5. PharmaResearch
      • 10.2.5.1. Company Overview
      • 10.2.5.2. Financial Performance
      • 10.2.5.3. Product Benchmarking
      • 10.2.5.4. Strategic Initiatives
    • 10.2.6. BRPHARM Co., Ltd.
      • 10.2.6.1. Company Overview
      • 10.2.6.2. Financial Performance
      • 10.2.6.3. Product Benchmarking
      • 10.2.6.4. Strategic Initiatives
    • 10.2.7. Teoxane
      • 10.2.7.1. Company Overview
      • 10.2.7.2. Financial Performance
      • 10.2.7.3. Product Benchmarking
      • 10.2.7.4. Strategic Initiatives
    • 10.2.8. Laboratoires VIVACY
      • 10.2.8.1. Company Overview
      • 10.2.8.2. Financial Performance
      • 10.2.8.3. Product Benchmarking
      • 10.2.8.4. Strategic Initiatives
    • 10.2.9. SKIN TECH PHARMA GROUP S.L.U.
      • 10.2.9.1. Company Overview
      • 10.2.9.2. Financial Performance
      • 10.2.9.3. Product Benchmarking
      • 10.2.9.4. Strategic Initiatives
    • 10.2.10. CAREGEN LTD
      • 10.2.10.1. Company Overview
      • 10.2.10.2. Financial Performance
      • 10.2.10.3. Product Benchmarking
      • 10.2.10.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제